New Advances in Transcatheter Aortic Valve Implantation

Dear Colleagues,

Aortic stenosis is the most common valvular disease worldwide and its burden will increase as the population ages. In the last twenty years, transcatheter aortic valve implantation (TAVI) has transitioned from being a treatment opportunity for patients who could not undergo surgery to the standard of care for most elderly patients, regardless of their surgical risk.

In this Special Issue, we will summarize current knowledge about the technical improvements that have allowed for a reduction in complications, higher safety and an expansion in indications. We will discuss how new transcatheter valve designs enable the patient-specific selection of devices according to individual anatomical restraints and risks, as well as how a comprehensive preprocedural work-up and wider operator experience are progressively transforming the use of alternative routes for patients with hostile femoral access into routine practice. We will also focus on issues about valve durability which have fostered advances in valve-in-valve planning, including new leaflet modification techniques.

For this Special Issue of JCDD, we welcome contributions focused on new advances in various domains related to TAVI, such as valve design, challenging anatomical subsets, alternative access, coronary obstruction prevention and new possibilities offered by computational models.

Dr Francesco Tartaglia is a cardiology fellow at the Cardio Center of Humanitas Research Hospital in Milan. His main research interests lie in structural heart disease, with a focus on transcatheter interventions and coronary artery disease, especially plaque modification devices and drug-coated balloons. Over the past years, he has contributed to the review process for various journals and conferences. He will assist Dr Mangieri in managing this Special Issue.

Dr. Antonio Mangieri
Guest Editor

Dr. Francesco Tartaglia
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• aortic stenosis
• transcatheter aortic valve replacement
• hostile access
• valve design
• bicuspid aortic valve
• aortic regurgitation
• valve-in-valve